MedTech News
.................... by Andrew Celentano
AI blood test detects early pancreatic cancer with up to 94% accuracy
A team of researchers from Taiwan has developed PanMETAI, an AI-powered platform that analyzes metabolic fingerprints in a simple blood sample to detect pancreatic cancer at its earliest stages—when treatment is most effective—achieving up to 94% diagnostic accuracy.
A safer, more effective atrial fibrillation treatment method using magnetic gel may be on the way
Researchers have developed a promising new treatment involving magnetic fluids.
BD picks up CE mark for Revello vascular covered stent
BD (NYSE: BDX)+ announced today that it received CE mark approval for its Revello vascular covered stent system.
Beating, 3D-printed heart model developed for surgical practice
Washington State University researchers have developed a 3D-printed model of the left side of the heart that contracts and beats, offering the chance for surgeons and medical students to rehearse important heart surgeries on a model that acts like the real thing.
In multiple sclerosis, wearable sensors may help identify people at risk of worsening disability
Wearable sensors may help identify people with multiple sclerosis (MS) who are more likely to have worsening disability and loss of brain volume, according to a study published in Neurology.
One-hour saliva test spots biomarker linked to several cancers
QUT researchers have developed a simple one-hour saliva test for a protein biomarker that has been linked with oral, colon and pancreatic cancers.
New AI tool predicts best pancreatic cancer treatment
A new tool co-developed by investigators from Cedars-Sinai Health Sciences University can predict which of two available chemotherapy options for pancreatic cancer would be more effective for an individual patient.
AI-based liquid biopsy may detect liver fibrosis, cirrhosis and chronic disease signals
Researchers at the Johns Hopkins Kimmel Cancer Center report that an artificial intelligence (AI)-based liquid biopsy test using genome-wide cell-free DNA (cfDNA) fragmentation patterns and repeat landscapes can detect early liver fibrosis and cirrhosis.